Dr. Roy S. Herbst, MD, PhD, Director, Dartmouth Cancer Center will be discussing cancer care and research at the Cancer Center. 

Roy Herbst, MD, PhD, was named the director of Dartmouth Cancer Center effective July 13, 2026. Dr. Herbst is internationally recognized as one of the foremost leaders in the development of targeted and immune-based therapies for the treatment of lung cancer. His work throughout the past three decades has significantly advanced the standard of care for patients with lung cancer, greatly enhancing survival and quality of life beyond what was previously thought to be possible. In this presentation Dr. Herbst will lay out his vision for the Dartmouth Cancer Center.

Throughout Dr. Herbst’s career, he has remained committed to delivering exceptional and compassionate patient care, producing top-notch translational research, and providing educational experiences to trainees that will prepare them for successful and meaningful careers. He promotes an atmosphere of collegiality and collaboration, building translational bridges between basic and clinical researchers, as well as between academic and industry partners.